Cargando…

The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels

INTRODUCTION: Copeptin is increasingly used in epidemiological studies as a substitute for vasopressin. The effect of renal function per se on copeptin and vasopressin concentrations as well as their ratio have, however, not been well described. METHODS: Copeptin and vasopressin levels were measured...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ettema, Esmée M., Heida, Judith, Casteleijn, Niek F., Boesten, Lianne, Westerhuis, Ralf, Gaillard, Carlo A.J.M., Gansevoort, Ron T., Franssen, Casper F.M., Zittema, Debbie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678637/ https://www.ncbi.nlm.nih.gov/pubmed/29142968 http://dx.doi.org/10.1016/j.ekir.2017.01.006

Ejemplares similares

Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment
por: Zittema, Debbie, et al.
Publicado: (2017)

Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?
por: Ettema, Esmée M., et al.
Publicado: (2015)

Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study
por: Ettema, Esmée M., et al.
Publicado: (2018)

Arginine Vasopressin and Copeptin in Perinatology
por: Evers, Katrina Suzanne, et al.
Publicado: (2016)

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)

Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients
por: Heida, Judith E., et al.
Publicado: (2021)

The Circadian Rhythm of Copeptin, the C-Terminal Portion of Arginine Vasopressin
por: Beglinger, Svetlana, et al.
Publicado: (2017)

A Joint Evaluation of Neurohormone Vasopressin-Neurophysin II-Copeptin and Aortic Arch Calcification on Mortality Risks in Hemodialysis Patients
por: Chang, Jia-Feng, et al.
Publicado: (2020)

Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD
por: Messchendorp, A. Lianne, et al.
Publicado: (2019)

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)
por: Riphagen, Ineke J., et al.
Publicado: (2013)

Arginine-vasopressin marker copeptin is a sensitive plasma surrogate of hypoxic exposure
por: Ostergaard, Louise, et al.
Publicado: (2014)

THU114 Postsurgical Use Of Copeptin In The Prediction Of Postoperative Arginine Vasopressin Deficiency
por: Erickson, Dana Z, et al.
Publicado: (2023)

Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker
por: North, William G
Publicado: (2023)

Copeptin in Hemodialysis Patients with Left Ventricular Dysfunction
por: Kim, Jae Seok, et al.
Publicado: (2015)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
por: Hofman, Jesse M. G., et al.
Publicado: (2018)

Nutritional Status in Nocturnal Hemodialysis Patients – A Systematic Review with Meta-Analysis
por: Ipema, Karin J. R., et al.
Publicado: (2016)

Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome
por: Karbek, Basak, et al.
Publicado: (2014)

Vasopressin and Prevention of Hypotension During Hemodialysis
por: Beladi Mousavi, Seyed Seifollah, et al.
Publicado: (2014)

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression
por: Messchendorp, A. Lianne, et al.
Publicado: (2017)

The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsia
por: de Fost, M, et al.
Publicado: (2015)

Vasopressin-related copeptin is a novel predictor of early endothelial dysfunction in patients with adult polycystic kidney disease
por: Kocyigit, Ismail, et al.
Publicado: (2016)

Limited Role of Endogenous Vasopressin/Copeptin in Stimulation of ACTH–Cortisol Secretion during Glucagon Stimulation Test in Humans
por: Malicka, Katarzyna, et al.
Publicado: (2022)

Tryptophan Intake and Tryptophan Losses in Hemodialysis Patients: A Balance Study
por: Post, Adrian, et al.
Publicado: (2019)

Amino Acid Homeostasis and Fatigue in Chronic Hemodialysis Patients
por: Post, Adrian, et al.
Publicado: (2022)

Lower body mass index and mortality in older adults starting dialysis
por: Polinder-Bos, Harmke A., et al.
Publicado: (2018)

Publisher Correction: Lower body mass index and mortality in older adults starting dialysis
por: Polinder-Bos, Harmke A., et al.
Publicado: (2018)

Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis
por: Meijers, Wouter C., et al.
Publicado: (2014)

Association between quality of life and various aspects of intradialytic hypotension including patient-reported intradialytic symptom score
por: Kuipers, Johanna, et al.
Publicado: (2019)

No Change in Nocturia After NOCTURNE
por: Meijer, Esther, et al.
Publicado: (2020)

Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”
por: Heida, Judith E., et al.
Publicado: (2021)

Prevalence of intradialytic hypotension, clinical symptoms and nursing interventions - a three-months, prospective study of 3818 haemodialysis sessions
por: Kuipers, Johanna, et al.
Publicado: (2016)

Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease
por: Messchendorp, A. Lianne, et al.
Publicado: (2018)

Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study
por: Agorastos, Agorastos, et al.
Publicado: (2020)

Vasopressin surrogate marker copeptin as a potential novel endocrine biomarker for antidepressant treatment response in major depression: A pilot study
por: Agorastos, A., et al.
Publicado: (2021)

Creatine homeostasis and protein energy wasting in hemodialysis patients
por: Post, Adrian, et al.
Publicado: (2021)

Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future
por: Noordzij, Marlies, et al.
Publicado: (2022)

Copeptin in anorexia nervosa
por: Goetze, Jens P., et al.
Publicado: (2020)

Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study
por: Arjune, Sita, et al.
Publicado: (2023)

The Presence of Kidney Cyst Infections in Patients With ADPKD After Kidney Transplantation: Need for Urological Analysis?
por: Geertsema, Paul, et al.
Publicado: (2022)

Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial
por: Casteleijn, Niek F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m66pgjb9uppi8ijhc3v2b8dali